Stockscreener 앱 받기
0.1295
9.19%
-0.0131
시간 외 거래:
.12
-0.0095
-7.34%
Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Price to earnings forward of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView
Form 4 Liminatus Pharma Inc For: 6 July By Investing.com - Investing.com Canada
4.37M Liminatus (NASDAQ: LIMN) shares moved in entity transfer - Stock Titan
Liminatus Pharma Closes InnocsAI Merger and Share Issuance - TipRanks
LIMNLiminatus Pharma Inc Options - Finviz
LIMN Should I Buy - Intellectia AI
Thursday's session: most active stocks - ChartMill
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Liminatus Pharma (LIMN) stock is trending overnight — here’s why it spiked over 30% in after-hours session (updated) - MSN
Liminatus Pharma (LIMN) Stock Is Trending Overnight — Here’s Why it Spiked Over 30% in After-Hours Sessio - Benzinga
Liminatus amends InnocsAI merger, closing set for July 2 - Investing.com
Trending Stocks Today | LogProStyle Surges 72.41% Post-Market - Moomoo
Wondering what's happening in today's after-hours session? - ChartMill
Liminatus amends InnocsAI merger, closing set for July 2 By Investing.com - Investing.com Canada
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline - The Manila Times
Liminatus pushes $320M InnocsAI merger to July 2 close - Stock Titan
Form PRE 14A Liminatus Pharma Inc For: 30 June By Investing.com - Investing.com Nigeria
Liminatus Pharma (LIMN) Edges Higher Amid Penny Stock VolatilityVolatility Stop - dars.gov.et
Liminatus Pharma (LIMN) Stock Forum and Discussion - Moomoo
Form S-1 Liminatus Pharma Inc For: 24 June By Investing.com - Investing.com Nigeria
Liminatus (NASDAQ: LIMN) resale S-1 and 1.6B-share InnocsAI merger plan - Stock Titan
Liminatus Pharma (LIMN) Faces Selling Pressure, Testing Key Support at $0.11Money Flow - newsline.com
Liminatus Pharma Warrants (LIMNW) Holds at $0.08 as Trading StallsPut Flow Alert - newsline.com
Liminatus Pharma (LIMN) Extends Decline, Testing Key Support at $0.11OBV Breakout - newsline.com
Liminatus Pharma Warrants (LIMNW) Hold Steady Near Key Support LevelVolume Oscillator - newsline.com
Liminatus Pharma (LIMN) Slips 5.77% as Selling Pressure Persists Below $0.14 ResistanceJelly Roll Trade - newsline.com
Liminatus Pharma Inc. (LIMN) Slides 5.95% as Stock Tests Key Support at $0.13Regression Channel - newsline.com
Liminatus Pharma secures $1.9M cash via warrant exercises - MSN
Liminatus Pharma Secures Liquidity Through Warrant Inducement Deal - TipRanks
[8-K] Liminatus Pharma, Inc. Reports Material Event - Stock Titan
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds - The Manila Times
Liminatus Pharma (NASDAQ: LIMN) cuts warrant exercise price; 13.8M warrants tied to 20.7M shares - Stock Titan
Liminatus Pharma (LIMN) Slides 8.89%: Testing Key $0.15 Support LevelVolatility Stop - newsline.com
Liminatus Pharma (LIMN) Slips 6% as Stock Tests Key Support at $0.16Order Block - newsline.com
LIMINATUS PHARMA, INC. Files Form 8-K for NASDAQ Listing – Company Information and SEC Filing Details - Minichart
Liminatus Pharma (LIMN) Holds Steady Near Resistance – Consolidation Phase May Precede Directional MoveSentiment Extreme - newsline.com
Liminatus Pharma Appeals Nasdaq Delisting, Listing Temporarily Intact - TipRanks
Liminatus Pharma Received Notice of Delisting - TradingView
Liminatus Pharma (LIMN) appeals Nasdaq delisting after market value shortfall - Stock Titan
Liminatus Pharma Inc. (LIMN) Surges Over 12% as Bullish Momentum BuildsBPI Reversal - The Legal Advocate
Liminatus Pharma - The Pharma Letter
Liminatus Pharma (LIMN) Shares Slide 3.25% as Selling Pressure Mounts Near SupportRetail Volume - newsline.com
Liminatus Pharma(LIMN) Stock Options Chain | Quotes & News - Moomoo
Liminatus announces proposed merger with InnocsAI - The Pharma Letter
Liminatus Pharma notifies NASDAQ of impending delisting; plans to appeal - MSN
Liminatus Pharma is trending overnight — here's why LIMN stock surged over 79% in after-hours session - MSN
Liminatus Pharma (LIMN) Faces Delisting from Nasdaq - GuruFocus
Liminatus Pharma (LIMN) Faces Nasdaq Delisting Notice Amid Compl - GuruFocus
1.17%
2.48%
자본화:
|
볼륨(24시간):